You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Review: metered dose inhalers with a holding chamber do not differ from nebulisers for hospital admission rates in asthma

Article Text

Article menu
Download PDFPDF
Treatment
Review: metered dose inhalers with a holding chamber do not differ from nebulisers for hospital admission rates in asthma

https://doi.org/10.1136/ebn.7.1.12

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Cates CC, Bara A, Crilly JA, et al. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003;(3):CD000052.

    Q In patients with acute asthma, is inhalation of β2 agonists from a metered dose inhaler (MDI) with a holding chamber more effective than inhalation from a nebuliser for reducing hospital admission rates or duration of inpatient stay?

    METHODS

    Embedded ImageData sources:

    Cochrane Airways Group Trials Register (November 2002), the Cochrane Library (2002, Issue 3), bibliographies of relevant articles, and individual researchers in the field.

    Embedded ImageStudy selection and assessment:

    randomised controlled trials (RCTs) published in any language that compared any β2 agonist given by an MDI with any holding chamber with the same β2 agonist given by any nebuliser in adults or children with acute …

    View Full Text

    Footnotes

    • For correspondence: Dr C Cates, Manor View Practice, Bushey Health Centre, Bushey, Hertfordshire, UK. chriscatesmsn.com

    • Sources of funding: Garfield Weston Foundation, UK and Canadian Institute on Health Research (CIHR), Ottawa, Canada.